AstraZeneca pipeline summary

Our pipeline summary is available to download (PDF 80.6 kb). This information was updated after our second quarter and half year results 2009, announced Thursday, 30 July 2009.

Please use the expanding table below to navigate the HTML version of the pipeline summary.

Comments

As disclosure of compound information is balanced by the business need to maintain confidentiality, information in relation to some compounds listed here has not been disclosed at this time.

Compounds in development are displayed by phase.

Key:

MAA – Marketing Authorisation Application (Europe).
NDA – New Drug Application/Biologics Licensing Application (USA).